Phillip D. Swanson

5.8k total citations · 1 hit paper
98 papers, 4.3k citations indexed

About

Phillip D. Swanson is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Phillip D. Swanson has authored 98 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Neurology, 35 papers in Molecular Biology and 35 papers in Cellular and Molecular Neuroscience. Recurrent topics in Phillip D. Swanson's work include Parkinson's Disease Mechanisms and Treatments (29 papers), Neuroscience and Neuropharmacology Research (19 papers) and Ion channel regulation and function (10 papers). Phillip D. Swanson is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (29 papers), Neuroscience and Neuropharmacology Research (19 papers) and Ion channel regulation and function (10 papers). Phillip D. Swanson collaborates with scholars based in United States, Italy and United Kingdom. Phillip D. Swanson's co-authors include Gary M. Franklin, Terri Smith‐Weller, Harvey Checkoway, W. T. Longstreth, Wilhelm Stahl, Karen M. Powers, William L. Stahl, Thomas D. Bird, W.T. Longstreth and M. William Lensch and has published in prestigious journals such as New England Journal of Medicine, Cell and JAMA.

In The Last Decade

Phillip D. Swanson

96 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DNA deletion associated with hereditary neuropathy with liability to pressure palsies

1993 606 citations Phillip D. Swanson, Thomas D. Bird et al. profile →

Peers

Phillip D. Swanson

NEURO

CMN

NEURO

PHYSI

Shigenobu Nakamura Japan

Ikuko Miyazaki Japan

André Barbeau Canada

A. Barbeau Canada

Sten‐Magnus Aquilonius Sweden

D. B. Calne Canada

Allen C. Bowling United States

Jay M. Gorell United States

Jaroslava Folbergrová Czechia

Hideo Tohgi Japan

Shigenobu Nakamura Japan

Phillip D. Swanson

1.7k ×1.0

NEURO

2.5k ×1.5

CMN

2.6k ×1.9

421 ×0.8

NEURO

1.0k ×2.4

PHYSI

Citations per year, relative to Phillip D. Swanson Phillip D. Swanson (= 1×) peers Shigenobu Nakamura

Countries citing papers authored by Phillip D. Swanson

Since Specialization

Citations

This map shows the geographic impact of Phillip D. Swanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip D. Swanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip D. Swanson more than expected).

Fields of papers citing papers by Phillip D. Swanson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip D. Swanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip D. Swanson. The network helps show where Phillip D. Swanson may publish in the future.

Co-authorship network of co-authors of Phillip D. Swanson

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip D. Swanson. A scholar is included among the top collaborators of Phillip D. Swanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip D. Swanson. Phillip D. Swanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Donghui, Emily Bonkowski, Olena Korvatska, et al.. (2015). ADCY5-related movement disorder: broader spectrum and genotype/phenotype correlations including new cases (P2.140). Neurology. 84(14_supplement). 2 indexed citations

Nielsen, Susan Searles, et al.. (2013). Nicotine, nightshades and Parkinson's disease. 25(3). 155–156. 1 indexed citations

Davis, Marie Y., et al.. (2013). Novel mutations in ataxia telangiectasia and AOA2 associated with prolonged survival. Journal of the Neurological Sciences. 335(1-2). 134–138. 9 indexed citations

Gallagher, Lisa G., Susan Searles Nielsen, Gary M. Franklin, et al.. (2013). Parkinson's disease and history of outdoor occupation. Parkinsonism & Related Disorders. 19(12). 1164–1166. 10 indexed citations

Bennett, James T., Kathleen B. Schwarz, Phillip D. Swanson, & Si Houn Hahn. (2012). An Exceptional Family with Three Consecutive Generations Affected by Wilson Disease. JIMD Reports. 10. 79–82. 12 indexed citations

Nielsen, Susan Searles, Lisa G. Gallagher, Jessica I. Lundin, et al.. (2011). Environmental tobacco smoke and Parkinson's disease. Movement Disorders. 27(2). 293–297. 53 indexed citations

Costa‐Mallen, Paola, Harvey Checkoway, Aram Zabeti, et al.. (2007). The functional polymorphism of the hemoglobin‐binding protein haptoglobin influences susceptibility to idiopathic Parkinson's disease. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 147B(2). 216–222. 28 indexed citations

Kelada, Samir N., Harvey Checkoway, Sharon L. R. Kardia, et al.. (2006). 5′ and 3′ region variability in the dopamine transporter gene ( SLC6A3 ), pesticide exposure and Parkinson's disease risk: a hypothesis-generating study. Human Molecular Genetics. 15(20). 3055–3062. 44 indexed citations

Ton, Thanh G.N., Susan R. Heckbert, W. T. Longstreth, et al.. (2006). Calcium channel blockers and β-blockers in relation to Parkinson's disease. Parkinsonism & Related Disorders. 13(3). 165–169. 42 indexed citations

10.

Ton, Thanh G.N., Susan R. Heckbert, W.T. Longstreth, et al.. (2006). Nonsteroidal anti‐inflammatory drugs and risk of Parkinson's disease. Movement Disorders. 21(7). 964–969. 112 indexed citations

11.

Powers, Karen M., Terri Smith‐Weller, Gary M. Franklin, et al.. (2005). Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk. Parkinsonism & Related Disorders. 12(3). 185–189. 75 indexed citations

12.

Kelada, Samir N., Patricia L. Stapleton, Federico M. Farin, et al.. (2003). Glutathione S-transferase M1, T1, and P1 Polymorphisms and Parkinson's Disease. Neuroscience Letters. 337(1). 5–8. 60 indexed citations

13.

Kelada, Samir N., Paola Costa‐Mallen, Lucio G. Costa, et al.. (2002). Gender Difference in the Interaction of Smoking and Monoamine Oxidase B Intron 13 Genotype in Parkinson’s Disease. NeuroToxicology. 23(4-5). 515–519. 36 indexed citations

14.

Farin, Federico M., James S. Woods, Patricia A. Janssen, et al.. (2001). Genetic polymorphisms of superoxide dismutase in Parkinson's disease. Movement Disorders. 16(4). 705–707. 20 indexed citations

15.

Zareparsi, Sepideh, Richard Camicioli, Gerard P. Sexton, et al.. (2001). Age at onset of Parkinson disease and apolipoprotein E genotypes. American Journal of Medical Genetics. 107(2). 156–161. 52 indexed citations

16.

Costa, Paola, Harvey Checkoway, Drew Levy, et al.. (1997). Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease. American Journal of Medical Genetics. 74(2). 154–156. 23 indexed citations

17.

Bronstein, Andrew D., et al.. (1993). Intraventricular fat from a ruptured sacral dermoid cyst: clinical, radiographic, and pathological correlation. Journal of neurosurgery. 78(4). 666–668. 37 indexed citations

18.

Pierelli, Francesco, Gian‐Emilio Chatrian, William W. Erdly, & Phillip D. Swanson. (1989). Long‐Term EEG‐Video‐Audio Monitoring: Detection of Partial Epileptic Seizures and Psychogenic Episodes by 24‐Hour EEG Record Review. Epilepsia. 30(5). 513–523. 60 indexed citations

19.

Schellenberg, Gerry, L. Anderson, & Phillip D. Swanson. (1983). Inhibition of Na+-Ca2+ exchange in rat brain by amiloride.. Molecular Pharmacology. 24(2). 251–258. 75 indexed citations

20.

Swanson, Phillip D., et al.. (1970). Diphenylhydantoin and the cations and phosphates of electrically stimulated brain slices. Neurology. 20(11). 1119–1119. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact